Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in Relx Plc $RELX

Key Points

• Empirical Financial Services LLC has acquired a new stake in Relx Plc, purchasing 6,827 shares valued at approximately $371,000 during the second quarter.
• Relx has announced a semi-annual dividend of $0.2634 per share, with a high dividend yield of 170.0% and a payout ratio of 28.49%.
• Several analysts have differing views on Relx's stock, with a mix of buy, hold, and strong buy ratings, reflecting a generally positive sentiment about the company.

Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new stake in shares of Relx Plc (NYSE:RELX - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 6,827 shares of the technology company's stock, valued at approximately $371,000.

A number of other institutional investors have also recently modified their holdings of RELX. Rhumbline Advisers grew its position in shares of Relx by 1.2% during the 1st quarter. Rhumbline Advisers now owns 34,906 shares of the technology company's stock valued at $1,760,000 after acquiring an additional 411 shares during the period. Merit Financial Group LLC grew its position in shares of Relx by 77.7% during the 1st quarter. Merit Financial Group LLC now owns 11,757 shares of the technology company's stock valued at $593,000 after acquiring an additional 5,139 shares during the period. Sivia Capital Partners LLC acquired a new stake in shares of Relx during the 1st quarter valued at about $224,000. Park Avenue Securities LLC grew its position in shares of Relx by 6.3% during the 1st quarter. Park Avenue Securities LLC now owns 65,050 shares of the technology company's stock valued at $3,279,000 after acquiring an additional 3,877 shares during the period. Finally, Portside Wealth Group LLC grew its position in shares of Relx by 2.8% during the 1st quarter. Portside Wealth Group LLC now owns 12,035 shares of the technology company's stock valued at $607,000 after acquiring an additional 325 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Relx Price Performance

RELX stock opened at $46.43 on Monday. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The business has a 50 day simple moving average of $47.85 and a 200-day simple moving average of $50.97. The firm has a market capitalization of $85.09 billion, a PE ratio of 24.96, a price-to-earnings-growth ratio of 3.03 and a beta of 0.87. Relx Plc has a 1 year low of $44.19 and a 1 year high of $56.33.

Relx Cuts Dividend

The business also recently declared a semi-annual dividend, which was paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th were given a $0.2634 dividend. The ex-dividend date was Friday, August 8th. This represents a dividend yield of 170.0%. Relx's dividend payout ratio is 28.49%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Weiss Ratings reiterated a "buy (b)" rating on shares of Relx in a report on Saturday, September 27th. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a report on Thursday, September 11th. Wall Street Zen cut Relx from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Finally, Kepler Capital Markets upgraded Relx from a "hold" rating to a "strong-buy" rating in a report on Thursday, September 18th. One analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Buy".

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.